Parfum de Chantecaille, Inc. – Trademark Portfolio

Entity Type: 03

Parfum de Chantecaille, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include KALIMANTAN, CHANTECAILLE, TIARE DE CHANTECAILLE, WISTERIA DE CHANTECAILLE, and FRANGIPANE DE CHANTECAILLE. The owner is based in New York, NY.

584 Broadway

Suite 1111

New York, NY 10012

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Parfum de Chantecaille, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (5 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Parfum de Chantecaille, Inc. have?

Parfum de Chantecaille, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Parfum de Chantecaille, Inc. file in?

Parfum de Chantecaille, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Parfum de Chantecaille, Inc.'s most well-known trademarks?

Parfum de Chantecaille, Inc.'s registered trademark portfolio includes well-known marks such as KALIMANTAN, CHANTECAILLE, TIARE DE CHANTECAILLE, WISTERIA DE CHANTECAILLE, and FRANGIPANE DE CHANTECAILLE. These are among 5 currently registered trademarks in the portfolio.

What is Parfum de Chantecaille, Inc.'s trademark registration success rate?

Parfum de Chantecaille, Inc. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.